HK Stock Market Move | The Hengke Index fell more than 3%, with all tech stocks trading in the red. Tencent (00700) reversed its gains in the afternoon.
Hengke's index fell by more than 3%, with all weighted technology stocks in the red. Tencent turned lower in the afternoon after rising more than 2% earlier, with both third quarter revenue and net profit beating expectations.
Heng Seng fell more than 3%, with all the constituent stocks of weighty tech stocks in the red. Tencent reversed its earlier gains in the afternoon, rising over 2%, with the company's third-quarter revenue and net profit exceeding expectations. As of the time of writing, KINGOFT (03888) fell by 3.73% to 28.4 Hong Kong dollars; BABA-W (09988) fell by 2.71% to 88.1 Hong Kong dollars; and Tencent (00700) fell by 0.3% to 402.6 Hong Kong dollars.
On the news front, on November 14th, during the Asian market session, the US Dollar Index maintained its intraday gains, rising to 106.69, reaching a one-year high. Zhongtai International pointed out that Trump's victory and trade protectionism tendencies have raised the risk premium for Hong Kong stocks, while strong inflation policies continue to drive the US dollar index and US bond yields, putting pressure on liquidity and valuation expansion in the Hong Kong stock market.
Open source securities also stated that the rapid increase followed by a pullback is a normal profit-taking adjustment, and in the next six months, a series of policies are expected to stimulate the basic fundamentals of the Chinese economy, providing support for the Hong Kong stock market. The macroeconomic outlook and corporate profit rebound in the future are expected to bring more long-term active funds back, suggesting that the Hong Kong stock market still has ample room for further upside.
Related Articles

ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
.png)
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of injectable BL-M24D1 (ADC) drug approved.

On October 21st, EDIANYUN (02416) spent 284,600 Hong Kong dollars to repurchase 135,000 shares.
ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)

Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of injectable BL-M24D1 (ADC) drug approved.
.png)
On October 21st, EDIANYUN (02416) spent 284,600 Hong Kong dollars to repurchase 135,000 shares.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025